| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Feb 4, 2025 | Zentalis Pharmaceuticals, Inc. | Director | Buy | 95.0 | +60,000 | 67.00% | ✗ | $103.4K |
| Sep 11, 2023 | Sep 13, 2023 | Zentalis Pharmaceuticals, Inc. | Director | Sell | 28.8 | -5,000 | -9.44% | ✓ | $125.2K |